Blood PSA testing is used as a screening test for prostate cancer. Prostate-specific antigen (PSA) levels by age remain the same across most populations. A PSA level above 4.0 ng/mL in any age group must be investigated. However, PSA levels can spike in noncancerous conditions, such as ...
PSA Chart PSA Test NumbersInterpretation Less than 4 ng/mLNormal 4– 10 ng/mL20 – 30 % risk of cancer 10 – 20 ng/mL50 – 75 % risk of cancer Above 20 ng/mL90 % risk of cancer PSA Levels by Age PSA LevelsNormal for Men ...
Blood samples were drawn and medical records were collected as part of an institutional PCa research database using standardised question- naires and chart abstraction forms. Pertinent clinical data included disease stage (TNM classification), Gleason score (from needle biopsy), PSA levels and age ...
associations between expression of ERG (as categorical variable) and continuous clin- ico-pathological parameters (age and PSA at the time of diagnosis) were tested using Student's t-test, and with categorical parameters (Gleason sum, pT- stage, surgical margins) using Pearson's w2 test. To...
The alert logic was validated by chart review using a convenience sample of 40 cases where a PSA test was ordered on men aged 75 and older. Of the 20 cases in which the alert would have been triggered, one was misclassified as a screening PSA because a pre-existing diagnosis of prostate...
Biochemical failure (BF) was defined by the Phoenix definition. Log-rank test was used for survival analysis. Results At a median follow-up of 38.2 months (standard deviation 22.2 months), 10 (4.9%) patients experienced BF. Concerning prostate cancer progression criteria, 52% of men ...